Argenx
ARGX
#579
Rank
S$48.31 B
Marketcap
$790.18
Share price
0.77%
Change (1 day)
17.51%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Argenx (ARGX) - Net assets

Net assets on the balance sheet as of June 2024 : S$5.65 Billion

According to Argenx 's latest financial reports the company has S$5.65 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Argenx - Net assets on balance sheet (from 2021 to 2020)

Net assets by year

Year Net assets Change
2022-12-31$S$3.77 B10.1%
2021-12-31$S$3.42 B25.77%
2020-12-31$S$2.72 B52.8%
2019-12-31$S$1.78 B85.21%
2018-12-31$S$0.96 B44.94%
2017-12-31$S$0.66 B554.5%
2016-12-31$S$0.10 B60.97%
2015-12-31$S$63.03 M-35.59%
2014-12-31$S$97.86 M86.62%
2013-12-31$S$52.44 M94.69%
2012-12-31$S$26.93 M-42.59%
2011-12-31$S$46.91 M167.63%
2010-12-31$S$17.53 M